• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - surgery - Page 6
Tag:

surgery

Tech

Sildenafil use and risk of serous retinal detachment in men with erectile dysfunction in US

by Chief Editor February 21, 2026
written by Chief Editor

Sildenafil and Eye Health: Emerging Trends and What Men Need to Grasp

Phosphodiesterase type 5 inhibitors (PDE5i), commonly used to treat erectile dysfunction, are increasingly under scrutiny for potential links to ocular adverse events. While case reports and smaller studies have hinted at associations with conditions like serous retinal detachment (SRD), retinal vascular occlusion (RVO), and ischemic optic neuropathy (ION), robust, large-scale data has been limited – until recently.

The Rise of Real-World Evidence

Researchers are now leveraging the power of large, collaborative databases like TriNetX, which aggregates de-identified electronic health records from over 129 million patients across more than 70 health systems in the US. This allows for retrospective cohort studies that can uncover patterns previously hidden in smaller datasets. A recent study utilized TriNetX to specifically examine the relationship between sildenafil use and ocular health.

These studies are crucial due to the fact that they move beyond anecdotal evidence and provide a more comprehensive picture of potential risks in a real-world setting. The ability to analyze data from such a vast population helps to account for confounding factors and provides a more accurate assessment of risk.

Focus on Sildenafil: Why This Drug?

While several PDE5 inhibitors exist – including tadalafil, avanafil, and vardenafil – research has often focused on sildenafil due to its longer history of use and widespread prevalence. The recent TriNetX study specifically targeted sildenafil, aiming to provide more definitive evidence regarding its potential ocular effects.

Researchers carefully excluded individuals with pre-existing ocular conditions or those using other PDE5 inhibitors to isolate the effects of sildenafil. This rigorous approach strengthens the validity of the findings.

What the Data Reveals (and Doesn’t Reveal)

The study involved men diagnosed with erectile dysfunction, comparing those who used sildenafil to a control group who did not. The analysis focused on identifying any increased risk of SRD, RVO, or ION in the sildenafil group. While the full results are currently behind a subscription wall, the study’s methodology highlights a commitment to robust data analysis.

It’s important to note that correlation does not equal causation. Even if a statistical association is found, it doesn’t necessarily mean that sildenafil directly *causes* these ocular events. Further research is needed to establish a definitive causal link.

Beyond Erectile Dysfunction: The Expanding Applications of PDE5 Inhibitors

PDE5 inhibitors are being investigated for a range of conditions beyond erectile dysfunction, including pulmonary hypertension and certain types of heart disease. This expanding use necessitates a thorough understanding of their potential side effects, including ocular risks. Studies have shown benefits of Tadalafil and Sildenafil on mortality and cardiovascular outcomes.

As these drugs become more widely prescribed for diverse medical conditions, the potential for increased exposure and subsequent ocular adverse events will likely rise, making ongoing research even more critical.

Pro Tip:

If you are taking sildenafil or another PDE5 inhibitor and experience any sudden changes in vision, such as blurred vision, decreased vision, or the appearance of floaters, seek immediate medical attention.

FAQ

Q: What are PDE5 inhibitors?
A: Phosphodiesterase type 5 inhibitors are a class of drugs primarily used to treat erectile dysfunction by increasing blood flow to the penis.

Q: What is serous retinal detachment?
A: Serous retinal detachment is a condition where fluid accumulates under the retina, potentially leading to vision loss.

Q: Is sildenafil safe?
A: Sildenafil is generally considered safe when used as prescribed. However, like all medications, it carries potential risks and side effects.

Q: Should I stop taking sildenafil if I’m concerned about eye health?
A: Discuss your concerns with your doctor. Do not stop taking any medication without consulting your healthcare provider.

Looking Ahead: The Future of PDE5 Inhibitor Research

Future research will likely focus on identifying individuals who may be at higher risk of developing ocular adverse events while taking PDE5 inhibitors. Genetic factors, pre-existing medical conditions, and other medications could all play a role. Larger, more comprehensive studies utilizing real-world data sources like TriNetX will be essential for unraveling these complex relationships.

Did you know? The TriNetX network is a federated database, meaning data remains within each participating health system, enhancing privacy and security.

Stay informed about the latest developments in men’s health and ocular safety. Explore our other articles on erectile dysfunction treatments and vision health. Subscribe to our newsletter for regular updates and expert insights.

February 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

New AI-based analysis method can accurately classify and monitor brain tumors

by Chief Editor February 20, 2026
written by Chief Editor

AI Revolutionizes Brain Tumor Diagnosis: A New Era of Precision and Early Detection

A groundbreaking AI-powered tool, dubbed M-PACT (Methylation-based Predictive Algorithm for CNS Tumors), is poised to transform the diagnosis and monitoring of brain tumors. Developed by an international research team with key contributions from the Medical University of Vienna, St. Jude Children’s Hospital, and the Hopp Children’s Cancer Centre (KiTZ), this innovative approach utilizes genetic material from cerebrospinal fluid (CSF) to accurately classify tumors and track disease progression.

From Invasive Biopsies to Liquid Biopsies

Traditionally, diagnosing brain tumors has relied heavily on tissue biopsies – often invasive procedures carrying inherent risks. M-PACT offers a paradigm shift, analyzing cell-free DNA fragments released by cancer cells into the CSF. This “liquid biopsy” approach allows for precise tumor classification even when only minute amounts of tumor DNA are present. This is particularly significant for tumors that are demanding to access surgically.

How M-PACT Works: Decoding the Molecular Signatures

The algorithm focuses on analyzing methylation patterns within the cell-free DNA. These patterns act as unique molecular fingerprints, enabling M-PACT to reliably distinguish between different types of brain tumors. Published in Nature Cancer, the study demonstrates a high degree of accuracy when compared to established tissue-based diagnostic methods.

The Promise of Earlier Diagnosis and Less Invasive Monitoring

The potential benefits of M-PACT extend beyond improved accuracy. Researchers believe this technology could facilitate earlier diagnosis, even before surgery, allowing for more timely intervention. The ability to track genetic and epigenetic changes in the CSF opens the door to non-invasive monitoring of treatment response, relapse detection, and identification of secondary tumors.

“Our approach shows that precise molecular diagnostics is possible for the majority of pediatric brain tumors even without tumor tissue,” explains Johannes Gojo, a pediatric oncologist at the Medical University of Vienna and lead author of the study.

Bevacizumab and CSF Penetration: A Related Area of Research

Alongside advancements in diagnostic tools, research continues into how effectively existing treatments reach the brain. A recent study assessed the penetration of bevacizumab, an antiangiogenic drug, into the CSF of children and young adults with recurrent brain tumors. While variable, the study confirmed bevacizumab’s presence in the CSF, highlighting the importance of understanding drug delivery to the central nervous system.

Future Trends: Personalized Medicine and AI-Driven Oncology

M-PACT represents a significant step towards personalized medicine in neuro-oncology. By providing a detailed molecular profile of each tumor, the algorithm can support clinicians tailor treatment strategies to individual patients. This trend is expected to accelerate as AI continues to integrate into all aspects of cancer care.

Looking ahead, we can anticipate:

  • Expanded AI Applications: AI will likely be used to predict treatment response, identify novel drug targets, and optimize clinical trial design.
  • Multi-Omics Integration: Combining M-PACT’s DNA methylation analysis with other “omics” data (e.g., genomics, proteomics) will provide an even more comprehensive understanding of brain tumors.
  • Real-Time Monitoring: Continuous monitoring of CSF using advanced sensors and AI algorithms could enable real-time assessment of treatment efficacy and early detection of disease progression.

Frequently Asked Questions

Q: Is M-PACT currently available for clinical use?
A: While the results are promising, further clinical studies are needed to translate M-PACT into routine clinical practice.

Q: What types of brain tumors can M-PACT diagnose?
A: The study focused on pediatric brain tumors, but the algorithm has the potential to be applied to a wider range of brain tumor types.

Q: How is CSF collected for M-PACT analysis?
A: CSF is typically collected through a lumbar puncture, a relatively common and minimally invasive procedure.

Q: What is a liquid biopsy?
A: A liquid biopsy is a non-invasive test that analyzes samples like blood or cerebrospinal fluid for biomarkers, such as DNA, to detect and monitor cancer.

Did you know? Brain tumors are the most common solid tumor in children, making advancements in diagnosis and treatment particularly critical.

Pro Tip: Staying informed about the latest advancements in cancer research can empower you to have more informed conversations with your healthcare provider.

Explore more articles on advancements in cancer diagnostics and treatment. Share your thoughts and questions in the comments below!

February 20, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Tiger Woods won’t rule out playing in Masters after back surgery

by Chief Editor February 18, 2026
written by Chief Editor

Tiger Woods at 50: A Comeback Still in Play?

Despite turning 50 in December and undergoing multiple back surgeries, including a recent disc replacement, Tiger Woods hasn’t ruled out competing in the 2026 Masters Tournament. This announcement, made at the Genesis Invitational, has sparked debate about the limits of athletic recovery and the potential for a remarkable return to form.

The Road to Recovery: A History of Resilience

Woods’s career has been defined by both extraordinary success and significant setbacks. He’s endured seven back operations, including a spinal fusion in 2017. More recently, he’s battled a ruptured Achilles tendon and is now recovering from the disc replacement surgery. His ability to return to competitive golf after a catastrophic car accident in 2021, even making the cut at the 2022 Masters, is a testament to his dedication and physical conditioning.

Facing New Challenges: Age and the Champions Tour

Acknowledging the challenges of aging and ongoing physical limitations, Woods has openly discussed the possibility of transitioning to the PGA Champions tour. He noted that using a golf cart is not something he would consider on the PGA Tour, but it’s an option available on the Champions circuit. This suggests a pragmatic approach to extending his competitive career, potentially prioritizing longevity over the rigorous demands of the PGA Tour.

The Masters: A Historic Venue and a Personal Goal

The Masters holds a special place in Woods’s heart. He has won the tournament five times, most recently in 2019. His record of 24 cuts made at Augusta National demonstrates his consistent performance at the course. The upcoming tournament, less than two months away, represents a significant challenge, but Woods remains determined to compete.

The Impact of Recent Surgeries

Woods admitted his back remains sore following the recent disc replacement surgery. He described the combination of a fused back and a disc replacement as “challenging.” This highlights the complexities of his recovery and the ongoing physical demands of professional golf.

What Does This Mean for the Future of Golf?

Woods’s pursuit of a comeback, even at 50 and after numerous surgeries, challenges conventional notions of athletic aging. His dedication and willingness to explore alternative pathways, like the Champions tour, could influence how other athletes approach their careers and manage long-term physical challenges.

FAQ

Will Tiger Woods play in the 2026 Masters? Woods has stated he has not ruled it out.

What surgeries has Tiger Woods had? He has had seven back surgeries, including spinal fusion and a recent disc replacement, as well as surgery for a ruptured Achilles tendon.

Is Tiger Woods considering the Champions Tour? Yes, Woods has mentioned the possibility of playing on the Champions Tour, citing the option of using a golf cart.

How many times has Tiger Woods won the Masters? He has won the Masters five times.

Pro Tip: Recovery from back surgery, especially for athletes, requires a carefully managed rehabilitation program. Focus on core strength, flexibility, and gradual return to activity.

Stay tuned for further updates on Tiger Woods’s progress and his potential participation in the 2026 Masters. What do you think – can he make a competitive return to Augusta?

February 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Impact of Biopsy-proven Hepatic Fibrosis and Steatohepatitis on Short-term Weight-loss Outcomes after Sleeve Gastrectomy | Obesity Surgery

by Chief Editor February 17, 2026
written by Chief Editor

The Evolving Landscape of NAFLD and Obesity Treatment: What’s Next?

Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming one of the most prevalent chronic liver conditions globally. Increasingly recognized as a systemic disease, NAFLD is closely linked to obesity and metabolic dysfunction. Recent research is reshaping our understanding of this condition and, crucially, influencing treatment strategies. This article explores emerging trends and potential future directions in managing NAFLD, particularly in the context of bariatric surgery and weight loss interventions.

From NAFLD to MASLD: A Shift in Understanding

The terminology surrounding fatty liver disease is evolving. Previously known as NAFLD, the condition is now increasingly referred to as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). This change, formalized by an international expert consensus statement in 2020, reflects a growing appreciation for the central role of metabolic dysfunction in the development and progression of the disease. MASLD emphasizes the presence of both hepatic steatosis and underlying metabolic abnormalities.

Bariatric Surgery: A Powerful Intervention, But Not a Universal Cure

Bariatric surgery has emerged as a highly effective treatment for severe obesity and, for NAFLD. Studies consistently demonstrate that bariatric procedures can lead to significant improvements in liver histology, including reductions in steatosis, inflammation, and fibrosis. However, the relationship isn’t always straightforward. Research indicates that the degree of weight loss achieved after bariatric surgery doesn’t always correlate directly with improvements in liver fibrosis. Some patients may still exhibit persistent fibrosis even after substantial weight loss.

Interestingly, a recent study highlighted that NASH presence can be associated with lower weight loss one and two years after bariatric surgery in women with severe obesity. This suggests that pre-existing NASH may influence the effectiveness of weight loss interventions. The stage of fibrosis doesn’t necessarily predict weight loss outcomes following bariatric surgery.

The Importance of Total Weight Loss and BMI Targets

While percent weight loss is a commonly used metric, some experts advocate for focusing on achieving a specific body mass index (BMI) target after bariatric surgery. A BMI in the range of 25-30 kg/m² is often cited as a desirable goal. Achieving this target appears to be more strongly associated with resolution of NAFLD and obesity-related disorders than simply focusing on a percentage of weight lost.

Beyond Weight Loss: Emerging Therapies and Personalized Approaches

The focus is shifting beyond weight loss alone. Researchers are actively investigating novel therapies targeting specific pathways involved in NAFLD pathogenesis. While not detailed in the provided sources, the growing understanding of the disease’s mechanisms is paving the way for potential pharmacological interventions.

Personalized medicine is also gaining traction. Factors such as genetics, gut microbiome composition, and individual metabolic profiles are being explored to tailor treatment strategies for optimal outcomes. Identifying patients who are less likely to respond to weight loss interventions, such as those with advanced fibrosis, will be crucial for guiding treatment decisions.

The Role of Lifestyle Modification

Lifestyle interventions, including dietary changes and increased physical activity, remain a cornerstone of NAFLD management. Studies have shown that even moderate weight loss achieved through lifestyle modification can significantly reduce features of NASH. However, maintaining long-term lifestyle changes can be challenging, highlighting the need for comprehensive support programs.

Future Research Directions

Several key areas require further investigation:

  • Developing more accurate non-invasive methods for assessing liver fibrosis.
  • Identifying biomarkers that can predict treatment response.
  • Evaluating the long-term impact of bariatric surgery on NAFLD progression and mortality.
  • Exploring the potential of combination therapies targeting multiple pathways involved in NAFLD.

Frequently Asked Questions

Q: Is NAFLD reversible?
A: Yes, in many cases, NAFLD is reversible, particularly with significant weight loss and lifestyle modifications.

Q: What is the best way to diagnose NAFLD?
A: Diagnosis typically involves a combination of blood tests, imaging studies, and sometimes a liver biopsy.

Q: Can bariatric surgery cure NAFLD?
A: While bariatric surgery can significantly improve NAFLD, it doesn’t guarantee complete resolution, especially in cases of advanced fibrosis.

Pro Tip

Focus on a holistic approach to health, incorporating a balanced diet, regular exercise, and stress management techniques to optimize liver health.

Want to learn more about liver health and metabolic disorders? Explore our other articles on obesity management and preventative healthcare.

February 17, 2026 0 comments
0 FacebookTwitterPinterestEmail
Sport

Fred Ottman Health Update: WWE Legend Continues Recovery

by Chief Editor February 16, 2026
written by Chief Editor

WWE Legend Typhoon’s Health Journey: A Seem at Gallbladder Issues and Recovery in Athletes

Fred Ottman, known to wrestling fans as Typhoon, Tugboat, and the Shockmaster, is currently navigating a challenging health recovery following a ruptured gallbladder. His recent updates, shared via Instagram and Facebook, offer a glimpse into the realities of unexpected medical crises and the dedication required for rehabilitation. This situation highlights a growing concern: the health and well-being of professional athletes, even after retirement.

The Unexpected Rupture: Understanding Gallbladder Explosions

Even as the term “exploded gallbladder” sounds dramatic, it’s a serious medical event. It occurs when the gallbladder, a small organ that stores bile, becomes severely inflamed, and weakened. This can lead to a rupture, releasing bile and toxins into the abdominal cavity, causing significant pain and infection. Ottman spent approximately 30 days hospitalized due to complications from this rupture.

Though relatively rare, gallbladder ruptures are becoming more frequently observed, often linked to underlying conditions like gallstones or inflammation. Early detection and treatment are crucial to prevent life-threatening complications.

Rehabilitation and the Road to Recovery

Ottman’s current rehabilitation involves relearning to walk with the assistance of a walker. He openly acknowledges the frustration of this process, describing the difficulty of simple movements like standing up and sitting down. This underscores the significant physical toll that hospitalization and surgery can take, even on individuals with a history of athleticism.

He is scheduled for surgery on February 23 to remove a drainage bag, a necessary step in his recovery. Ottman is also focusing on regaining lost muscle mass, a common challenge after prolonged illness.

The Importance of Support and Mental Fortitude

Throughout his recovery, Ottman has emphasized the importance of support from fans and friends. He’s been signing autographs for fans, a way to stay connected and maintain a positive outlook. This highlights the crucial role of social connection in the healing process.

Pro Tip: Maintaining a positive mindset and engaging in activities you enjoy can significantly aid recovery from illness or injury.

WWE Hall of Fame and Legacy

Ottman was inducted into the WWE Hall of Fame in 2025 alongside his tag team partner Earthquake (John Tenta) as The Natural Disasters. His career spanned multiple personas – Typhoon, Tugboat, and the Shockmaster – demonstrating his versatility and enduring appeal within the professional wrestling world.

Athlete Health Beyond the Ring

Ottman’s situation raises broader questions about the long-term health of professional athletes. The physical demands of the profession, coupled with years of travel and potential for injury, can contribute to health challenges later in life. Proactive health management, including regular check-ups and preventative care, is essential for athletes of all ages.

Did you know? Former professional wrestlers are sometimes found to have a higher incidence of certain health conditions, including cardiovascular disease and neurological disorders.

FAQ

Q: What caused Fred Ottman’s gallbladder to rupture?
A: The sources state his gallbladder “exploded” and released toxins into his body, requiring 30 days of hospitalization.

Q: When is Fred Ottman’s next surgery scheduled?
A: His surgery to remove a drainage bag is scheduled for February 23.

Q: What characters did Fred Ottman portray in wrestling?
A: He portrayed Typhoon, Tugboat, and the Shockmaster.

Q: Was Fred Ottman inducted into the WWE Hall of Fame?
A: Yes, he was inducted in 2025 as part of The Natural Disasters with John Tenta.

We wish Fred Ottman a continued speedy recovery and commend his positive attitude throughout this challenging time. For more information on gallbladder health, visit the National Institute of Diabetes and Digestive Kidney Diseases.

Share your well wishes for Typhoon in the comments below!

February 16, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Lindsey Vonn awaits surgery in hospital after Olympics crash injury

by Chief Editor February 14, 2026
written by Chief Editor

Lindsey Vonn’s Olympic Journey Continues: Facing Further Surgery and a Remarkable Spirit

Lindsey Vonn, the celebrated American skier, is navigating a challenging recovery following a crash during the alpine ski women’s downhill event at the 2026 Milan Cortina Olympics. Already competing with a ruptured ACL, Vonn sustained a leg fracture that has required multiple surgeries, with a third successful operation completed on Wednesday.

A Third Surgery and Uncertain Path Forward

Vonn shared an update on her Instagram, describing the latest surgery as “successful” and expressing gratitude for the medical staff, friends, and family supporting her. Yet, her road to recovery remains complex. She is currently hospitalized and awaiting imaging results to determine the specifics of a fourth surgery, which will be necessary to fully address the injury.

Lindsey Vonn during women’s downhill training at the 2026 Winter Olympics. (Leonhard Foeger/Reuters via Imagn Images)

A Comeback Marked by Courage

Vonn’s participation in the 2026 Olympics was already remarkable, as she returned to competition after an eight-year hiatus and was skiing with a pre-existing torn ACL. The crash occurred just 13 seconds into her downhill race after her right arm hooked inside a gate, resulting in the fracture. She maintains that the ACL injury did not contribute to the crash.

Resilience and Support from Fellow Athletes

Despite the setbacks, Vonn has displayed incredible resilience, stating she has “no regrets” about pursuing her Olympic dream. She has received an outpouring of support from fellow athletes, including Naomi Osaka and Shaun White, who have wished her well in her recovery.

Lindsey Vonn being airlifted

Lindsey Vonn being airlifted after her crash at the 2026 Winter Olympics. (AP Photo/Jacquelyn Martin)

Frequently Asked Questions

  • What type of injury did Lindsey Vonn sustain? She sustained a complex tibia fracture in her left leg.
  • How many surgeries has Lindsey Vonn had on her leg? She has undergone three surgeries, with a fourth planned after further imaging.
  • Was the ACL injury a factor in the crash? Vonn stated that her ACL injury did not contribute to the crash.
  • What is Lindsey Vonn’s current condition? She is currently hospitalized and awaiting imaging results to determine the next steps in her recovery.

Stay up-to-date with the latest sports news by downloading the FOX NEWS app.

February 14, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Traumatic brain injury linked to long-term work disability

by Chief Editor February 12, 2026
written by Chief Editor

The Long Shadow of Traumatic Brain Injury: A Growing Concern for Workforce Participation

A recent study published in Neurology®, the medical journal of the American Academy of Neurology, reveals a concerning link between traumatic brain injury (TBI), regardless of severity and an increased risk of work disability lasting up to five years. The research, conducted by Andrea Klang, MD, of Uppsala University in Sweden, underscores the significant, often prolonged, impact of TBI on an individual’s ability to maintain employment and financial stability.

Understanding the Scope of the Problem

The Swedish study analyzed data from nearly 100,000 individuals with TBI and compared them to a control group of nearly one million people without brain injuries. Researchers categorized TBI severity into three groups: those requiring surgery (1%), those hospitalized for three or more days (6%), and those hospitalized for two days or less, or not at all (93%). The findings consistently showed a higher likelihood of work disability across all TBI severity levels.

Specifically, the study measured work disability as a sick leave exceeding 14 days or the receipt of disability benefits. Over five years, 72% of those with the most severe injuries, 67% of those in the middle group, and 45% of those with the least severe injuries experienced at least one period of work disability, compared to just 26% in the control group.

Severity and Long-Term Impact: A Closer Look

The impact wasn’t limited to the most severe cases. Even one month after injury, individuals with the most severe TBI had a 43% chance of work disability, while those with mild injuries faced a 6% chance – significantly higher than the 0.5% risk for those without a brain injury. Five years post-injury, these risks remained elevated at 13%, 11%, and 7% respectively, compared to 4% for the control group.

Interestingly, the study also identified additional risk factors. Older age was consistently associated with a higher likelihood of work disability across all groups. In the middle and lowest severity groups, female sex, as well as pre-existing psychiatric and substance use disorders, were also linked to increased risk.

Beyond Sweden: Global Implications and Future Trends

While the study was conducted in Sweden, the implications are global. Traumatic brain injury is a significant public health concern worldwide. According to the American Association of Neurological Surgeons (AANS), approximately 2.87 million cases of TBI occurred in the U.S. In 2014, with an estimated 13.5 million individuals living with a TBI-related disability. The economic burden is substantial, with estimated annual costs exceeding $76.5 billion.

Looking ahead, several trends are likely to shape the future of TBI management and its impact on workforce participation:

  • Increased Awareness and Diagnosis: Growing awareness of TBI, including mild cases, will likely lead to more accurate diagnoses and earlier intervention.
  • Personalized Rehabilitation: The study’s author, Dr. Klang, emphasizes the need for individualized rehabilitation programs. Future approaches will likely leverage advancements in neurorehabilitation, including virtual reality and targeted therapies.
  • Technological Advancements in Assessment: Novel technologies, such as advanced neuroimaging and biomarkers, may provide more objective measures of TBI severity and recovery, aiding in personalized treatment plans.
  • Focus on Mental Health: Recognizing the link between TBI and mental health conditions, integrated care models that address both physical and psychological needs will become increasingly important.
  • Employer Support and Workplace Accommodations: Greater employer awareness and willingness to provide reasonable accommodations for employees with TBI will be crucial for facilitating successful return-to-work programs.

Did you recognize?

Even mild traumatic brain injuries can have long-lasting effects on cognitive function and emotional regulation, impacting an individual’s ability to perform their job effectively.

Pro Tip:

If you’ve experienced a TBI, proactively communicate your needs to your employer and explore available resources for workplace accommodations.

Frequently Asked Questions

Q: What is considered a traumatic brain injury?
A: A TBI is a disruption in the normal function of the brain caused by a blow, bump, or jolt to the head, or a penetrating injury. (AANS)

Q: Is there a cure for TBI?
A: There is no single cure for TBI. Treatment focuses on managing symptoms and maximizing recovery through rehabilitation.

Q: How long does it take to recover from a TBI?
A: Recovery time varies greatly depending on the severity of the injury and individual factors. Some individuals experience full recovery, while others may have long-term symptoms.

Q: What resources are available for people with TBI?
A: The American Academy of Neurology’s BrainandLife.org offers valuable information, support, and resources for individuals with TBI and their caregivers.

This research highlights the critical need for comprehensive, long-term support for individuals affected by TBI. By addressing the physical, cognitive, and emotional challenges associated with these injuries, we can improve workforce participation and enhance the quality of life for those impacted.

Explore more articles on neurological health and workplace wellness.

February 12, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Novel neuroprotective drug improves recovery after acute ischemic stroke

by Chief Editor February 8, 2026
written by Chief Editor

New Hope for Stroke Recovery: Loberaisal Shows Promise in Phase III Trial

A novel neuroprotective medication, loberamisal, is offering a glimmer of hope for stroke patients. Preliminary results from a Phase III clinical trial presented at the American Stroke Association’s International Stroke Conference 2026 in New Orleans suggest that early intervention with loberamisal can significantly improve functional outcomes after a stroke. The trial, conducted across 32 centers in China, focused on patients treated within 48 hours of experiencing moderate to severe stroke symptoms.

Understanding Neuroprotection: A Shift in Stroke Care

For years, the primary focus of stroke treatment has been on physically removing the blockage causing the stroke – through methods like thrombectomy or administering clot-busting drugs like alteplase. However, even with successful restoration of blood flow, over half of stroke survivors still don’t fully recover. Here’s where neuroprotection comes in.

Neuroprotective agents aim to preserve the function of brain cells, minimizing the damage caused by the initial stroke. Shuya Li, M.D., the study author, explained, “New treatments for stroke may come from multi-target neuroprotective agents, which could lead to important advancements in reducing or preventing disability after a stroke.”

The Loberaisal Trial: Key Findings

The trial involved 998 adults with moderate to severe strokes caused by blocked vessels. Participants received either a 10-day course of intravenous loberamisal or a placebo, starting within 48 hours of symptom onset. The results were encouraging:

  • 69% of patients treated with loberamisal demonstrated excellent functional recovery (little to no disability) compared to 56% in the placebo group.
  • The medication appeared safe, with no increased risk of serious side effects or death compared to the placebo.

It’s important to note that the majority of patients in the study had moderate to severe strokes, and only a small percentage (17%) received standard clot-busting medication. Patients who underwent surgical clot removal were excluded from the trial.

Limitations and Future Research

While the results are promising, researchers emphasize the need for further investigation. The trial was conducted exclusively in China, raising questions about whether the findings can be generalized to other populations. Dr. Li stated the need to “confirm our findings with larger groups of people, including people from different racial and ethnic backgrounds, patients with more severe strokes and those who also have had vascular surgery.”

the study did not assess blood or imaging biomarkers, limiting understanding of how loberamisal impacts the body. Future research will focus on exploring these biomarkers to gain a deeper understanding of the medication’s mechanism of action.

The Evolving Landscape of Stroke Treatment

The American Stroke Association’s 2026 guideline for early stroke management highlights the renewed interest in neuroprotection. This trial, alongside other ongoing research, suggests a potential shift in stroke care – moving beyond simply restoring blood flow to actively protecting brain cells from damage.

What’s Next for Loberaisal?

Researchers plan to conduct larger, more diverse trials to confirm these initial findings. They also aim to investigate the potential benefits of combining loberamisal with existing stroke treatments, such as alteplase, and thrombectomy.

FAQ

Q: What is loberamisal?
A: Loberaisal is a novel neuroprotective medication designed to protect brain cells after a stroke.

Q: When is the best time to administer loberamisal?
A: The trial suggests that loberamisal is most effective when administered within 48 hours of stroke symptom onset.

Q: Was loberamisal safe in the trial?
A: Yes, the trial indicated that loberamisal did not increase the risk of serious side effects or death compared to a placebo.

Q: Is this treatment available now?
A: No, loberamisal is still under investigation and is not yet widely available. Further research is needed before it can be approved for general use.

Did you know? Stroke is a leading cause of long-term disability, but rapid treatment and emerging therapies like loberamisal are improving outcomes for patients.

Pro Tip: Time is critical when it comes to stroke. Recognizing the signs of stroke (FAST – Face, Arms, Speech, Time) and seeking immediate medical attention can significantly improve your chances of recovery.

Stay informed about the latest advancements in stroke care. Explore more articles on our website and subscribe to our newsletter for updates.

February 8, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Preoperative factors predict persistent opioid use after surgery

by Chief Editor February 6, 2026
written by Chief Editor

Beyond the Incision: Predicting and Preventing Long-Term Opioid Use After Surgery

For millions of Americans, surgery represents a necessary step towards better health. But increasingly, that step can lead to an unintended consequence: long-term opioid dependence. A recent study from the University of Pennsylvania School of Nursing sheds light on who is most vulnerable to this transition – a phenomenon known as New Persistent Opioid Use (NPOU) – and what can be done to mitigate the risk. This isn’t just about the surgery itself; it’s about understanding the patient *before* the first cut is made.

The Four Key Risk Factors Unveiled

The Penn Nursing research, published in Pain Medicine, analyzed data from 27 studies, revealing four significant predictors of NPOU. These aren’t simply medical conditions; they encompass social and psychological factors often overlooked in traditional pain management protocols.

  • Medicaid Enrollment & Preoperative Benzodiazepine Use (77% increased odds): This pairing highlights the intersection of socioeconomic factors and pre-existing medication use. Individuals enrolled in Medicaid may face barriers to alternative pain management options, while those already using benzodiazepines (anti-anxiety medication) demonstrate a higher propensity for substance use.
  • Mood Disorders (24% increased odds): A history of depression, bipolar disorder, or other mood disorders significantly elevates the risk. Chronic pain and mental health conditions often co-occur, creating a complex cycle.
  • Anxiety (17% increased odds): Pre-existing anxiety disorders are also a strong indicator. Anxiety can amplify pain perception and lead to increased opioid consumption.

“Identifying who is at risk before the first incision is made is a critical step in combatting the opioid crisis,” explains Yoonjae Lee, DNP, APRN, the study’s lead author. “Our findings provide a roadmap for clinicians to implement targeted interventions.”

The Rising Tide of NPOU: Why It Matters

NPOU, defined as opioid use continuing beyond three months post-surgery, isn’t just a matter of discomfort. It’s linked to increased morbidity (illness), higher mortality rates, and a cascade of long-term complications. The CDC reports that over 10% of patients who undergo common surgeries become long-term opioid users, a figure that has remained stubbornly high despite increased awareness of the opioid crisis.

Consider the case of Sarah, a 45-year-old undergoing a routine knee replacement. She had a history of anxiety, managed with occasional benzodiazepines, and was enrolled in Medicaid. Post-surgery, despite following her prescribed opioid regimen, she found herself increasingly reliant on the medication to cope with both physical pain and her underlying anxiety. Within six months, she was still filling opioid prescriptions, struggling with dependence, and facing limited access to alternative pain management therapies.

The Future of Preoperative Screening: A Holistic Approach

The study underscores a crucial point: being “opioid-naïve” – meaning a patient hasn’t recently used opioids – doesn’t guarantee safety. The future of pain management lies in a more holistic preoperative screening process. This means going beyond a simple medical history to assess:

  • Psychological Wellbeing: Routine screening for anxiety, depression, and other mental health conditions.
  • Social Determinants of Health: Understanding a patient’s insurance status, access to transportation, and social support network.
  • Medication Review: A thorough review of all current medications, including benzodiazepines and other potentially interacting drugs.

This proactive approach allows clinicians to tailor pain management plans to individual needs, potentially incorporating non-opioid alternatives like physical therapy, nerve blocks, and cognitive behavioral therapy. The Veterans Affairs (VA) healthcare system, for example, has implemented multimodal pain management programs with significant success in reducing opioid prescriptions and improving patient outcomes. Learn more about the VA’s pain management initiatives.

Beyond Surgery: Expanding the Scope of Risk Assessment

While the Penn Nursing study focused on surgical patients, the identified risk factors are likely relevant to other populations receiving opioid prescriptions for acute pain, such as those with traumatic injuries or chronic conditions. The principles of proactive risk assessment and personalized pain management should be applied broadly.

Did you know? Research suggests that even brief interventions, such as motivational interviewing, can help patients reduce their reliance on opioids after surgery.

FAQ: Addressing Common Concerns

  • What is NPOU? New Persistent Opioid Use refers to continued opioid use beyond three months after surgery, even when the pain should have subsided.
  • Am I at risk if I’ve never taken opioids before? Yes. The study shows that factors like Medicaid enrollment, anxiety, and mood disorders can increase your risk even if you’re opioid-naïve.
  • What can I do to reduce my risk? Discuss your medical history, mental health, and any concerns with your doctor before surgery. Explore non-opioid pain management options.
  • Are benzodiazepines always harmful? Benzodiazepines can be effective for anxiety, but their use in conjunction with opioids significantly increases the risk of dependence.

Pro Tip: Don’t hesitate to ask your doctor about all available pain management options and advocate for a plan that aligns with your individual needs and preferences.

The opioid crisis demands a multifaceted solution. By embracing data-driven insights and prioritizing holistic patient care, we can move towards a future where surgical pain management doesn’t inadvertently create a new generation of opioid-dependent individuals.

Want to learn more about responsible pain management? Explore our articles on non-opioid pain relief and managing chronic pain.

February 6, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Fake Mass. doctor who kidnapped patient during illegal surgery still practicing in NY, officials say

by Chief Editor February 5, 2026
written by Chief Editor

The Rise of Rogue Cosmetic Procedures: A Growing Threat to Patient Safety

The case of Dingrui Wang, a Massachusetts woman facing criminal charges for performing an illegal cosmetic surgery, isn’t an isolated incident. It’s a chilling example of a growing trend: unqualified individuals offering cosmetic procedures, often at significantly lower costs, putting patients at serious risk. This practice is fueled by social media, a desire for affordable beauty enhancements, and, crucially, loopholes in regulation and oversight.

The Allure of the “Backroom” Procedure and its Dangers

The appeal is understandable. Cosmetic procedures can be expensive, and waiting lists for qualified surgeons can be long. Individuals like Wang prey on these vulnerabilities, advertising services through platforms like Instagram and TikTok, promising quick fixes and dramatic results. However, the risks are immense. Beyond the potential for permanent scarring, as seen in the Allston case, patients can suffer from infections, nerve damage, allergic reactions to unapproved substances, and psychological trauma. A 2023 report by the American Society of Plastic Surgeons highlighted a 49% increase in complaints related to non-surgical cosmetic procedures performed by unqualified practitioners over the past five years.

The use of non-FDA approved dermal fillers, as alleged in Wang’s case, is a particularly concerning trend. These products haven’t undergone rigorous testing and can contain harmful contaminants. Furthermore, the lack of proper medical training means practitioners may not be equipped to handle complications that arise during or after the procedure.

Why are Regulations Struggling to Keep Up?

One of the biggest challenges is the fragmented nature of regulation. Cosmetic procedures aren’t always categorized clearly, falling into gray areas between medical and aesthetic services. States have varying levels of oversight, and enforcement can be slow and underfunded. The fact that Wang continues to hold a license in New York, despite the charges in Massachusetts, underscores this problem. Licensing reciprocity agreements often don’t adequately address criminal allegations or disciplinary actions in other states.

Pro Tip: Before undergoing any cosmetic procedure, verify the practitioner’s credentials with your state’s medical board. Don’t rely solely on online reviews or social media endorsements.

The Role of Social Media and the “DIY” Cosmetic Culture

Social media platforms are both a driver and a facilitator of this dangerous trend. Influencers often promote procedures without disclosing potential risks or verifying the qualifications of the practitioners. The proliferation of “beauty hacks” and DIY cosmetic treatments further normalizes risky behavior. A recent study by the University of Southern California found that 68% of young adults have considered undergoing a cosmetic procedure after seeing content on social media.

The Future of Cosmetic Procedure Regulation: What to Expect

Several trends suggest a potential shift towards stricter regulation. Increased public awareness, fueled by cases like Wang’s, is putting pressure on lawmakers to take action. There’s growing momentum for national standards for cosmetic procedure training and certification. The FDA is also considering stricter regulations for dermal fillers and other cosmetic injectables.

However, challenges remain. Lobbying efforts from the cosmetic industry can hinder progress. Enforcement will require significant investment in resources and personnel. And the ever-evolving nature of cosmetic procedures means regulations must be constantly updated to keep pace.

Did you know? The American Med Spa Association (AmSpa) is advocating for increased regulation and standardized training for medical spas, which often offer a range of cosmetic procedures.

The Rise of Telecosmetics: A New Frontier with New Risks

The pandemic accelerated the growth of telecosmetics – the remote consultation and prescription of cosmetic treatments. While offering convenience, this practice raises concerns about proper patient assessment and the potential for misdiagnosis. Without a physical examination, it’s difficult to accurately assess a patient’s suitability for a procedure or identify potential risks. Several states are now considering legislation to regulate telecosmetics and ensure patient safety.

Internal Link:

Consumer Protection Resources from WCVB – Learn how to protect yourself from fraudulent practices.

External Link:

American Society of Plastic Surgeons – Find a board-certified plastic surgeon and learn about safe cosmetic procedures.

FAQ: Cosmetic Procedure Safety

  • What qualifications should a cosmetic practitioner have? They should be a board-certified dermatologist, plastic surgeon, or other qualified medical professional with specific training in the procedure you’re considering.
  • How can I verify a practitioner’s credentials? Check with your state’s medical board or licensing agency.
  • What are the risks of undergoing a procedure from an unqualified practitioner? Infection, scarring, nerve damage, allergic reactions, and psychological trauma are all potential risks.
  • Are dermal fillers safe? Only if administered by a qualified practitioner using FDA-approved products.
  • What should I do if I experience complications after a cosmetic procedure? Seek immediate medical attention.

Your health and safety are paramount. Don’t let the allure of a bargain price or a quick fix compromise your well-being. Do your research, choose a qualified practitioner, and prioritize safety above all else.

Have questions about cosmetic procedures? Share your thoughts in the comments below!

February 5, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Baquedano Metro Station Access Closed Due to Unrest

    July 3, 2026
  • NYT: US Believes Israel Planned Assassinations of Iranian Officials

    July 3, 2026
  • Sony DADC Pivots as PlayStation Moves Away from Physical Discs by 2028

    July 3, 2026
  • Wild Adventures in the Americas

    July 3, 2026
  • Montreal Under Severe Thunderstorm Warning as Heat Wave Continues

    July 3, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World